Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERMfiledCriticalInstitut National de la Sante et de la Recherche Medicale INSERM
Priority to FR7735825ApriorityCriticalpatent/FR2409991B2/fr
Publication of FR2409991A2publicationCriticalpatent/FR2409991A2/fr
Application grantedgrantedCritical
Publication of FR2409991B2publicationCriticalpatent/FR2409991B2/fr
C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
FR7735825A1977-11-291977-11-29(chloro-2' benzoyl)-6 benzoxazolinone, utilisable comme medicament
ExpiredFR2409991B2
(fr)